Verrica Pharmaceuticals Statistics
Total Valuation
VRCA has a market cap or net worth of $109.26 million. The enterprise value is $80.74 million.
Important Dates
The next estimated earnings date is Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRCA has 17.18 million shares outstanding. The number of shares has increased by 105.61% in one year.
| Current Share Class | 17.18M |
| Shares Outstanding | 17.18M |
| Shares Change (YoY) | +105.61% |
| Shares Change (QoQ) | +48.68% |
| Owned by Insiders (%) | 29.17% |
| Owned by Institutions (%) | 18.32% |
| Float | 6.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.07 |
| Forward PS | 4.31 |
| PB Ratio | 4.42 |
| P/TBV Ratio | 4.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.59 |
| Quick Ratio | 2.16 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.54 |
Financial Efficiency
Return on equity (ROE) is -240.35% and return on invested capital (ROIC) is -23.90%.
| Return on Equity (ROE) | -240.35% |
| Return on Assets (ROA) | -14.74% |
| Return on Invested Capital (ROIC) | -23.90% |
| Return on Capital Employed (ROCE) | -38.90% |
| Weighted Average Cost of Capital (WACC) | 17.44% |
| Revenue Per Employee | $468,118 |
| Profits Per Employee | -$235,342 |
| Employee Count | 76 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 5.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.78% in the last 52 weeks. The beta is 1.43, so VRCA's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | +36.78% |
| 50-Day Moving Average | 5.75 |
| 200-Day Moving Average | 5.89 |
| Relative Strength Index (RSI) | 54.46 |
| Average Volume (20 Days) | 80,389 |
Short Selling Information
The latest short interest is 581,329, so 3.38% of the outstanding shares have been sold short.
| Short Interest | 581,329 |
| Short Previous Month | 497,753 |
| Short % of Shares Out | 3.38% |
| Short % of Float | 8.58% |
| Short Ratio (days to cover) | 5.30 |
Income Statement
In the last 12 months, VRCA had revenue of $35.58 million and -$17.89 million in losses. Loss per share was -$1.68.
| Revenue | 35.58M |
| Gross Profit | 23.28M |
| Operating Income | -11.94M |
| Pretax Income | -17.89M |
| Net Income | -17.89M |
| EBITDA | -11.45M |
| EBIT | -11.94M |
| Loss Per Share | -$1.68 |
Full Income StatementBalance Sheet
The company has $30.15 million in cash and $1.63 million in debt, with a net cash position of $28.52 million or $1.66 per share.
| Cash & Cash Equivalents | 30.15M |
| Total Debt | 1.63M |
| Net Cash | 28.52M |
| Net Cash Per Share | $1.66 |
| Equity (Book Value) | 24.74M |
| Book Value Per Share | 1.44 |
| Working Capital | 26.10M |
Full Balance SheetCash Flow
| Operating Cash Flow | -17.63M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 485,000 |
| Net Borrowing | -48.20M |
| Free Cash Flow | -17.63M |
| FCF Per Share | -$1.03 |
Full Cash Flow StatementMargins
Gross margin is 65.44%, with operating and profit margins of -33.56% and -50.27%.
| Gross Margin | 65.44% |
| Operating Margin | -33.56% |
| Pretax Margin | -50.27% |
| Profit Margin | -50.27% |
| EBITDA Margin | -32.19% |
| EBIT Margin | -33.56% |
| FCF Margin | n/a |
Dividends & Yields
VRCA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -105.61% |
| Shareholder Yield | -105.61% |
| Earnings Yield | -16.37% |
| FCF Yield | -16.13% |
Analyst Forecast
The average price target for VRCA is $17.00, which is 165.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.00 |
| Price Target Difference | 165.00% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 30.55% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 25, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 25, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
VRCA has an Altman Z-Score of -7.48 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.48 |
| Piotroski F-Score | 4 |
